stella
beta
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease — Stella
Recruiting
Back to Beta-Thalassemia trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(6 sites)
United States
New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York, New York
Levine Children's Hospital - Hematology, Charlotte, North Carolina
TriStar Medical Group Children's Specialists - Pediatric Oncology, Nashville, Tennessee
Germany
University Hospital Dusseldorf - Department of Pediatric Oncology, Hematology and Clinical Immunology, Düsseldorf
Italy
IRCSS Ospedale Pediatrico Bambino Gesu - Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica, Rome
Show all 6 locations
View full record on ClinicalTrials.gov